{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Paperboy.FM Presents...","title":"mRNA cancer vaccines — Paperboy.FM Presents","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/0867f66a\"></iframe>","width":"100%","height":180,"duration":3050,"description":"This week’s papers tell a consistent story: mRNA cancer vaccines are moving from broad promise to more practical questions about delivery, personalization, combinations, and who might actually benefit first. 499 papers, 2022–2026. Sponsored by Paperboy.FM Presents.","thumbnail_url":"https://img.transistorcdn.com/dpOSBGwUuWvA4LhE92v_MDUXP4cV8alPkXC9Fy_sQ-Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS8xNGE1/ZWI5MTRlZjEzOTUx/NGMwYjM2ZDU2ZTI5/ZjRjNC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}